LF
IDXX icon

Lantz Financial’s Idexx Laboratories IDXX Stock Holding History

Lantz Financial’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-385
Closed -$216K – 262
2026
Q1 		$216K Sell
385
-1
-0.3% -$641 0.04% 230
2025
Q4 		$261K Buy
386
+5
+1% +$3.4K 0.06% 223
2025
Q3 		$243K Sell
381
-13
-3% -$7.89K 0.05% 225
2025
Q2 		$211K Buy
+394
New +$188K 0.05% 227

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
MIM
Manitou Investment Management Toronto, Ontario, Canada $538M AUM 13.79% 1-Year Est. Return
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.5B AUM 31.02% 1-Year Est. Return

Lantz Financial's IDXX Position: Q2 2026 in Review

Lantz Financial sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 385 shares — an estimated $216K sold.

Lantz Financial first reported a position in IDXX in Q2 2025 and held it in 4 quarters. The position peaked at $261K in Q4 2025. 235 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Lantz Financial reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Lantz Financial sold 385 Idexx Laboratories shares in Q2 2026, an estimated $216K.
  • Lantz Financial first reported a position in Idexx Laboratories in Q2 2025 and held it in 4 quarters.
  • Lantz Financial's Idexx Laboratories position peaked at $261K in Q4 2025.
  • 235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.